HealthSouth Corporation (HLS) Rating Lowered to Sell at Zacks Investment Research
HealthSouth Corporation (NYSE:HLS) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Wednesday.
According to Zacks, “HEALTHSOUTH Corp. is the one of the nation’s largest providers of outpatient surgery and rehabilitative healthcare services. The company provides these services through its national network of inpatient and outpatient healthcare facilities, including inpatient and outpatient rehabilitation facilities, outpatient surgery centers, diagnostic centers, occupational medicine centers, medical centers and other healthcare facilities. “
Several other research analysts also recently commented on the stock. Piper Jaffray Companies restated a “hold” rating and set a $50.00 price objective on shares of HealthSouth Corporation in a research report on Sunday, September 17th. KeyCorp reaffirmed a “hold” rating on shares of HealthSouth Corporation in a research note on Thursday, September 7th. Royal Bank Of Canada reaffirmed a “buy” rating and set a $55.00 target price on shares of HealthSouth Corporation in a research note on Wednesday, September 6th. ValuEngine cut shares of HealthSouth Corporation from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Finally, Stephens started coverage on shares of HealthSouth Corporation in a research note on Thursday, August 31st. They set an “overweight” rating and a $53.00 target price on the stock. Three analysts have rated the stock with a sell rating, four have given a hold rating and three have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $49.71.
HealthSouth Corporation (HLS) traded up 0.87% on Wednesday, reaching $46.50. The company’s stock had a trading volume of 168,668 shares. The firm has a market capitalization of $4.59 billion, a P/E ratio of 16.95 and a beta of 0.58. The firm has a 50-day moving average price of $44.86 and a 200 day moving average price of $45.19. HealthSouth Corporation has a 52-week low of $36.97 and a 52-week high of $49.71.
HealthSouth Corporation (NYSE:HLS) last announced its quarterly earnings data on Monday, July 31st. The company reported $0.71 EPS for the quarter, beating the consensus estimate of $0.68 by $0.03. HealthSouth Corporation had a net margin of 6.70% and a return on equity of 25.07%. The business had revenue of $981.30 million during the quarter, compared to the consensus estimate of $976.46 million. During the same period in the previous year, the business earned $0.69 earnings per share. The company’s revenue was up 6.6% on a year-over-year basis. Equities analysts anticipate that HealthSouth Corporation will post $2.71 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This story was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark laws. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/10/06/healthsouth-corporation-hls-rating-lowered-to-sell-at-zacks-investment-research.html.
In related news, CEO Mark J. Tarr sold 22,625 shares of the business’s stock in a transaction on Monday, August 7th. The shares were sold at an average price of $43.00, for a total value of $972,875.00. Following the sale, the chief executive officer now owns 283,134 shares of the company’s stock, valued at $12,174,762. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 1.60% of the company’s stock.
A number of hedge funds have recently added to or reduced their stakes in the stock. World Asset Management Inc lifted its holdings in HealthSouth Corporation by 0.8% in the first quarter. World Asset Management Inc now owns 5,487 shares of the company’s stock valued at $235,000 after buying an additional 41 shares during the period. Teacher Retirement System of Texas lifted its holdings in HealthSouth Corporation by 0.7% in the second quarter. Teacher Retirement System of Texas now owns 7,117 shares of the company’s stock valued at $344,000 after buying an additional 48 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its holdings in HealthSouth Corporation by 0.5% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 13,072 shares of the company’s stock valued at $633,000 after buying an additional 64 shares during the period. NGAM Advisors L.P. lifted its holdings in HealthSouth Corporation by 1.4% in the second quarter. NGAM Advisors L.P. now owns 10,448 shares of the company’s stock valued at $506,000 after buying an additional 142 shares during the period. Finally, Renaissance Group LLC lifted its holdings in HealthSouth Corporation by 1.9% in the second quarter. Renaissance Group LLC now owns 8,288 shares of the company’s stock valued at $401,000 after buying an additional 152 shares during the period. Institutional investors and hedge funds own 93.04% of the company’s stock.
HealthSouth Corporation Company Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Receive News & Stock Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related stocks with our FREE daily email newsletter.